$6.41
+0.28 (+4.57%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where BODI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional
Held by 3 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC) · FINRA short interest 10.8 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| The Effect of a High Protein, High Fiber Dietary Supplement on Weight and Fat LossNCT03057873Change in body weight (kg)Randomized · Quadruple-masked · Other | Not applicable | Completed | Dietary supplement: High protein, high fiber dietary supplement, Placebo | Overweight | 206 | 2018-10-25actual | 2019-02-04 |
| The Effect of a High Protein, High Fibre Shake Pre-load on Measures of Satiety and Subsequent Energy IntakeNCT02979717Energy intake (total kilocalories) at meal subsequent to intervention pre-loadRandomized · Triple-masked · Other | Not applicable | Completed | Dietary supplement: High protein, high fiber dietary supplement · Other: Low protein, low fiber comparator | Overweight and Obesity | 50 | 2017-03-14actual | 2017-03-29 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19